Ryunosuke Machida - Japan Clinical Oncology Group Data Center/Operations Office, National Cancer Center Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 93 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Status of Incremental Costs of First-Line Treatment Recommended in Japanese Clinical Guidelines for Metastatic Breast Cancer Patients

Tsuguo Iwatani,Keita Sasaki,Ryunosuke Machida,Tadahiko Shien,Fumikata Hara,Tomomi Fujisawa,Yuko Takano,Yoshie Kobayashi,Michiyo Saimura,Kei Koizumi,Mitsuo Terada,Shinsuke Sasada,Kanako Saito, Miwa Sumiyoshi,Hiroji Iwata

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2024)

引用0浏览0WOS引用

Upfront Allo-Hsct after Intensive Chemotherapy for Untreated Aggressive ATL: JCOG0907, a Single-Arm, Phase 3 Trial

Takuya Fukushima, Kunihiro Tsukasaki,Ryunosuke Machida,Dai Maruyama,Shinichi Makita,Shigeru Kusumoto,Shinsuke Iida, Masahito Tokunaga,Yasushi Miyazaki,Makoto Yoshimitsu,Ilseung Choi,Sawako Nakachi,Kana Miyazaki,Junya Makiyama,Kisato Nosaka, Hiroo Katsuya,Toshiro Kawakita, Taro Shibata,Haruhiko Fukuda, Hirokazu Nagai

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Randomized Phase III Study Comparing Re-Irradiation Stereotactic Body Radiotherapy and Conventional Radiotherapy for Painful Spinal Metastases: Japan Clinical Oncology Group Study JCOG2211 (RESCORE Study)

Ryosuke Kita, Kei Ito,Ryunosuke Machida,Yuta Sekino,Naoki Nakamura,Yujiro Nakajima, Tetsuo Saito, Nobuki Imano,Haruhiko Fukuda,Yoshinori Ito, Takashi Mizowaki, Japan Clinical Oncology Group Radiation Therapy Study Group

Japanese journal of clinical oncology (2024)

引用0浏览0WOS引用

Novel Approach of Prophylactic Radiation to Reduce Toxicities Comparing 2-Step40 with 56-Gy Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck, an Intergroup Phase III Trial (JCOG1912, NEW BRIDGE)

Tomoya Yokota,Sadamoto Zenda,Takeshi Kodaira,Naomi Kiyota,Yasushi Fujimoto,Koichiro Wasano,Ryo Takahashi,Takashi Mizowaki,Akihiro Homma,Keita Sasaki,Ryunosuke Machida,Yuta Sekino,Haruhiko Fukuda

Journal of Clinical Oncologyno. 16_suppl (2024): TPS6121-TPS6121

引用0浏览0WOS引用

691: A Single-Arm Confirmatory Trial of IMRT Alone for Early-Stage Oropharyngeal Cancer: JCOG1208

Satoaki Nakamura, Takeshi Kodaira,Ryunosuke Machida,Takeo Nakashima, Yoshinori Ito, Naoki Nakamura,Satoshi Ishikura,Takashi Toshiyasu, Yoshihiro Saito,Satoru Takahashi, Yosuke Ota,Masahiro Inada, Yuji Murakami,Nobuteru Kubo,Yuta Sekino,Haruhiko Fukuda, Yasumasa Nishimura, Takashi Mizowaki

Radiotherapy and Oncology (2024)

引用0浏览0引用

Prognostic Evaluation of the Ki-67 Labeling System in Histological Grading of Non-Small Round Cell Sarcoma: a Supplementary Analysis of a Randomized Controlled Trial, JCOG1306

Shintaro Sugita,Kazuhiro Tanaka,Yoshinao Oda,Takayuki Nojima, Naomi Konishi,Ryunosuke Machida,Ryosuke Kita,Haruhiko Fukuda,Toshifumi Ozaki,Tadashi Hasegawa

JAPANESE JOURNAL OF CLINICAL ONCOLOGYno. 6 (2024): 675-680

引用0浏览0WOS引用

Integrated Analysis of Two Phase 2 Trials of Nivolumab in Metastatic Rare Solid Cancer with Dmmr or Pmmr (MASTER KEY Sub-Studies: ROCK and ROLL Trial)

Masashi Kanai,Hitomi Sumiyoshi Okuma,Kenji Tsuchihashi,Ryunosuke Machida,Ryo Sadachi,Akihiro Hirakawa, Masahisa Kamikura,Kenta Anjo,Shigeki Sekine,Natsuko Tsuda Okita,Kenichi Nakamura,Kan Yonemori

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

A Randomized Controlled Trial of Metastasisdirected Therapy for Oligometastases in Breast Cancer (OLIGAMI Trial; JCOG2110)

Toshiyuki Ishiba,Ikuno Nishibuchi, Fumitaka Hara,Keita Sasaki, Ryo Sadate,Yuta Sekino,Ryunosuke Machida,Haruhiko Fukuda,Takahiro Kogawa,Tomomi Fujisawa,Yasuaki Sagara,Yoichi Naito,Kaori Terata,Yukinori Ozaki,Akihiko Shimomura, Takehiko Sakai,Chizuko Kanbayashi,Tsuguo Iwatani,Hideo Shigematsu,Kenji Tamura, Takashi Mizowaki, Michio Yoshimura,Naoto Shikama,Tadahiko Shien,Hiroji Iwata

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn